AARS1 and inborn mitochondrial metabolism disorder: To address this possibility, and to extend to other pathogenic mitochondrial tRNA mutations associated with mitochondrial diseases (e.g., in mitochondrial tRNAVal [51]), the label-free assay would be preferable, because it can readily accommodate high concentrations of tRNA while maintaining the relative concentration of the aaRS low enough to detect aminoacylation.